Pacific Biosciences
PACB
PACB
118 hedge funds and large institutions have $590M invested in Pacific Biosciences in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.82% more ownership
Funds ownership: 70.68% → 74.5% (+3.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
40% less call options, than puts
Call options by funds: $627K | Put options by funds: $1.04M
Holders
118
Holding in Top 10
2
Calls
$627K
Puts
$1.04M
Top Buyers
| 1 | +$22.5M | |
| 2 | +$13.9M | |
| 3 | +$12.3M | |
| 4 |
RI
RTW Investments
New York
|
+$12.1M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.66M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$4.05M | |
| 3 | -$3.23M | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$1.72M |
| 5 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$928K |